That's like saying I made a prediction of x amount looking into my crystal ball and I was wrong. Obviously Macquarie hasn't done their homework and not enough research and too bullish, it's their problem. If u look at the prospectus they pretty much hit all the hurdles apart from ARPU. All other growth metrics are positive. Surely one persons opinion (obviously they were wrong) cannot affect the price of a stock by 40%. And reaffirmed guidance is a good thing and not a bad thing, it's too early to say what Veya will do but they did say it will affect the EPS from FY17 not FY16 so again makes no sense.
And not aware response is possibly naive on the part of AYS as a less than 10% miss on one metric does or shouldn't equate to a market update especially since there are many metrics which were positive. If the ARPU affected the bottom line by 10% or more then they have some explaining to do.
I think it's more on the crazy list, not the naughty list
AYS Price at posting:
$1.47 Sentiment: Hold Disclosure: Held
